<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23629944</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4598</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Muscle &amp; nerve</Title><ISOAbbreviation>Muscle Nerve</ISOAbbreviation></Journal><ArticleTitle>Androgen receptors in muscle fibers induce rapid loss of force but not mass: implications for spinal bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>823</StartPage><EndPage>834</EndPage><MedlinePgn>823-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.23813</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Testosterone (T) induces motor dysfunction in transgenic (Tg) mice that overexpress wild-type androgen receptor (AR) in skeletal muscles. Because many genes implicated in motor neuron disease are expressed in skeletal muscle, mutant proteins may act in muscle to cause dysfunction in motor neuron disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We examined contractile properties of the extensor digitorum longus (EDL) and soleus (SOL) muscles in vitro after 5 and 3 days of T treatment in motor-impaired Tg female mice.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both muscles showed deficits in tetanic force after 5 days of T treatment, without losses in muscle mass, protein content, or fiber number. After 3 days of T treatment, only SOL showed a deficit in tetanic force comparable to that of 5 days of treatment. In both treatments, EDL showed slowed twitch kinetics, whereas SOL showed deficits in the twitch/tetanus ratio.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results suggest calcium-handling mechanisms in muscle fibers are defective in motor-impaired mice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oki</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Michigan State University, 108 Giltner Hall, 293 Farm Lane, East Lansing, Michigan 48824-1101, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiseman</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Breedlove</LastName><ForeName>S Marc</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Cynthia L</ForeName><Initials>CL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK095210</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS045195</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Muscle Nerve</MedlineTA><NlmUniqueID>7803146</NlmUniqueID><ISSNLinking>0148-639X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009119" MajorTopicYN="N">Muscle Contraction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23629944</ArticleId><ArticleId IdType="mid">NIHMS575529</ArticleId><ArticleId IdType="pmc">PMC4015727</ArticleId><ArticleId IdType="doi">10.1002/mus.23813</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, Oppenheim RW. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci. 2006;26(34):8774&#x2013;8786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674380</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F, Oudart H, Halter B, Huze C, Schaeffer L, Bouillaud F, Loeffler JP. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One. 2009;4(4):e5390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun S, Croizat B, Lagrange MC, Warter JM, Poindron P. Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet. 1995;345(8951):694&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">7741893</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes-Diaz C, Frugier T, Tiziano FD, Lacene E, Roblot N, Joshi V, Moreau MH, Melki J. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J Cell Biol. 2001;152(5):1107&#x2013;1114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2198815</ArticleId><ArticleId IdType="pubmed">11238465</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, Lieberman AP, Breedlove SM, Jordan CL. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A. 2007;104(46):18259&#x2013;18264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci. 2007;10(5):608&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet. 2010;19(11):2284&#x2013;2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischbeck KH. Kennedy disease. J Inherit Metab Dis. 1997;20(2):152&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">9211187</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol. 2009;65(2):140&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS, Chang C. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med. 2007;13(3):348&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">17334372</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 2006;116(10):2663&#x2013;2672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35(5):843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinirons P, Rouleau GA. Administration of testosterone results in reversible deterioration in Kennedy&#x2019;s disease. J Neurol Neurosurg Psychiatry. 2008;79(1):106&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">17056629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, O&#x2019;Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP, Merry DE. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci. 2004;24(20):4778&#x2013;4786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen JA, Yu Z, Mo K, Monks DA, Lieberman AP, Breedlove SM, Jordan CL. Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy. Neurobiol Dis. 2009;34(1):113&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209964</ArticleId><ArticleId IdType="pubmed">19211034</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen JA, Troxell-Smith SM, Yu Z, Mo K, Monks DA, Lieberman AP, Breedlove SM, Jordan CL. Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy. Neurodegener Dis. 2011;8(1&#x2013;2):25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030474</ArticleId><ArticleId IdType="pubmed">20689246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopher BL, Thomas PS, Jr, LaFevre-Bernt MA, Holm IE, Wilke SA, Ware CB, Jin LW, Libby RT, Ellerby LM, La Spada AR. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron. 2004;41(5):687&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15003169</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MT, Kushmerick MJ. Chemical energetics of slow- and fast-twitch muscles of the mouse. J Gen Physiol. 1982;79(1):147&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2215489</ArticleId><ArticleId IdType="pubmed">7061985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushmerick MJ, Moerland TS, Wiseman RW. Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi. Proc Natl Acad Sci U S A. 1992;89(16):7521&#x2013;7525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49742</ArticleId><ArticleId IdType="pubmed">1502163</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin JD, Scott RL, West JM, Lopes E, Quah AK, Cheema SS. Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul Disord. 2005;15(5):377&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">15833433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol. 2008;586(14):3337&#x2013;3351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapointe BM, Cote CH. Anesthetics can alter subsequent in vitro assessment of contractility in slow and fast skeletal muscles of rat. Am J Physiol. 1999;277(3 Pt 2):R917&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">10484512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiseman RW, Beck TW, Chase PB. Effect of intracellular pH on force development depends on temperature in intact skeletal muscle from mouse. Am J Physiol. 1996;271(3 Pt 1):C878&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">8843718</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentel JN, Blanchard SG, Ankrapp DP, McCabe LR, Wiseman RW. Inhibition of cross-bridge formation has no effect on contraction-associated phosphorylation of p38 MAPK in mouse skeletal muscle. Am J Physiol Cell Physiol. 2005;288(4):C824&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">15574487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns SP, Chin ER, Renaud JM. Stimulation pulse characteristics and electrode configuration determine site of excitation in isolated mammalian skeletal muscle: implications for fatigue. J Appl Physiol. 2007;103(1):359&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">17412789</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen JA, Breedlove SM, Jordan CL. Androgen receptor expression in the levator ani muscle of male mice. J Neuroendocrinol. 2007;19(10):823&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">17850465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuloaga DG, Morris JA, Jordan CL, Breedlove SM. Mice with the testicular feminization mutation demonstrate a role for androgen receptors in the regulation of anxiety-related behaviors and the hypothalamic-pituitary-adrenal axis. Horm Behav. 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18775430</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraman RC, Latourette MT, Siebert JE, Wiseman RW. A rapid algorithm for processing digital physiologic signals: Application to skeletal muscle contractions. Biomedical Signal Processing and Control. 2006;1:307&#x2013;313.</Citation></Reference><Reference><Citation>Johnson RT, Schneider A, DonCarlos LL, Breedlove SM, Jordan CL. Astrocytes in the rat medial amygdala are responsive to adult androgens. J Comp Neurol. 2012;520(11):2531&#x2013;2544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209966</ArticleId><ArticleId IdType="pubmed">22581688</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, O&#x2019;Bryant EL, Jordan CL. Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction. J Comp Neurol. 2004;473(1):59&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15067718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab. 2004;89(10):5245&#x2013;5255.</Citation><ArticleIdList><ArticleId IdType="pubmed">15472231</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando SM, Rao P, Niel L, Chatterjee D, Stagljar M, Monks DA. Myocyte Androgen Receptors Increase Metabolic Rate and Improve Body Composition by Reducing Fat Mass. Endocrinology. 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2903941</ArticleId><ArticleId IdType="pubmed">20427479</ArticleId></ArticleIdList></Reference><Reference><Citation>Musa M, Fernando SM, Chatterjee D, Monks DA. Subcellular effects of myocyte-specific androgen receptor overexpression in mice. J Endocrinol. 2011;210(1):93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555343</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold MW, Brinkmeier H, Muntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev. 2000;80(3):1215&#x2013;1265.</Citation><ArticleIdList><ArticleId IdType="pubmed">10893434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger AM, Reiken S, Dura M, Murphy PW, Deng SX, Landry DW, Nieman D, Lehnart SE, Samaru M, LaCampagne A, Marks AR. Remodeling of ryanodine receptor complex causes &#x201c;leaky&#x201d; channels: a molecular mechanism for decreased exercise capacity. Proc Natl Acad Sci U S A. 2008;105(6):2198&#x2013;2202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2538898</ArticleId><ArticleId IdType="pubmed">18268335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009;15(3):325&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910579</ArticleId><ArticleId IdType="pubmed">19198614</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A, Marks AR. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 2011;14(2):196&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3690519</ArticleId><ArticleId IdType="pubmed">21803290</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology. 2002;59(5):770&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve. 2009;40(1):126&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">19533663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce JM, Pennington RJ, Walton JN. Serum Enzyme Studies in Muscle Disease. Ii. Serum Creatine Kinase Activity in Muscular Dystrophy and in Other Myopathic and Neuropathic Disorders. J Neurol Neurosurg Psychiatry. 1964;27:96&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC495703</ArticleId><ArticleId IdType="pubmed">14167093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, Neale G, Taylor JP. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67(6):936&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti C, Castellotti B, Pareyson D, Testa D, Eoli M, Antozzi C, Silani V, Marconi R, Tezzon F, Siciliano G, Marchini C, Gellera C, Donato SD. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord. 2000;10(6):391&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>